The extent of responses to ICI is related to multiple factors, including tumor and tumor-environment factors (PD-L1 expression in tumor cells, cytokines, tumor mutational burden, personal and health factors, performance status at the start of ICI, body mass index) [4]. Here, CD274 is linked to neoplasm.